Use of a Simple in vitro Test to Assess Loss of Chemical due to Volatility during an in vitro Human Skin Absorption Study.


Journal

Skin pharmacology and physiology
ISSN: 1660-5535
Titre abrégé: Skin Pharmacol Physiol
Pays: Switzerland
ID NLM: 101188418

Informations de publication

Date de publication:
2019
Historique:
received: 30 10 2018
accepted: 18 01 2019
pubmed: 20 3 2019
medline: 21 11 2019
entrez: 20 3 2019
Statut: ppublish

Résumé

We tested the cutaneous distribution of 50 chemicals in frozen human skin. The mass balance (MB) values for 48% of the chemicals were < 90%, possibly due to evaporation. We confirmed the reduction in MB was due to evaporation for two chemicals tested in skin penetration experiments using a carbon filter above the skin to trap airborne chemical. An in vitro assay was used to predict the reduction in MB due to evaporation by comparing the recovery of chemicals after 4 h of incubation at room temperature in open and closed vials. Evaporative losses in vitro correlated well with measured MBs (i.e., < 90%) in skin penetration experiments (R2 = 0.81). There was a correlation of the MB with the vapour pressure (VP) which could be used to group chemicals according to their likelihood to evaporate during the course of a skin penetration study. There was also a correlation of MB with Henry's law constants, melting and boiling points. Our data support the use of a quick and simple test for volatility to account for the loss of MB in skin penetration experiment due to volatility. The best parameter to indicate the potential of a chemical to evaporate is the VP.

Sections du résumé

BACKGROUND BACKGROUND
We tested the cutaneous distribution of 50 chemicals in frozen human skin. The mass balance (MB) values for 48% of the chemicals were < 90%, possibly due to evaporation.
METHODS METHODS
We confirmed the reduction in MB was due to evaporation for two chemicals tested in skin penetration experiments using a carbon filter above the skin to trap airborne chemical. An in vitro assay was used to predict the reduction in MB due to evaporation by comparing the recovery of chemicals after 4 h of incubation at room temperature in open and closed vials.
RESULTS RESULTS
Evaporative losses in vitro correlated well with measured MBs (i.e., < 90%) in skin penetration experiments (R2 = 0.81). There was a correlation of the MB with the vapour pressure (VP) which could be used to group chemicals according to their likelihood to evaporate during the course of a skin penetration study. There was also a correlation of MB with Henry's law constants, melting and boiling points.
CONCLUSION CONCLUSIONS
Our data support the use of a quick and simple test for volatility to account for the loss of MB in skin penetration experiment due to volatility. The best parameter to indicate the potential of a chemical to evaporate is the VP.

Identifiants

pubmed: 30889606
pii: 000497105
doi: 10.1159/000497105
doi:

Substances chimiques

Pharmaceutical Preparations 0
Carbon 7440-44-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-124

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Sébastien Grégoire (S)

L'Oreal Research and Innovation, Aulnay-sous-Bois, France.

Richard Cubberley (R)

Unilever, Sharnbrook, United Kingdom.

Hélène Duplan (H)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Joan Eilstein (J)

L'Oreal Research and Innovation, Aulnay-sous-Bois, France.

Nicola J Hewitt (NJ)

Cosmetics Europe, Brussels, Belgium, nickyhewittltd@yahoo.co.uk.

Carine Jacques-Jamin (C)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Camille Genies (C)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Martina Klaric (M)

Cosmetics Europe, Brussels, Belgium.

Helga Rothe (H)

Procter & Gamble (currently Coty), Darmstadt, Germany.

Corie Ellison (C)

The Procter & Gamble Company, Cincinnati, Ohio, USA.

Julien Fernandez (J)

Eurofins I ADME Bioanalysis, Vergèze, France.

Andreas Schepky (A)

Beiersdorf AG, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH